Antimicrobial susceptibility and metallo-β-lactamase production among Pseudomonas aeruginosa isolated from Makkah hospitals

Pakistan Journal of Medical Sciences

Volumn 28, Issue 5, 2012, Pages 7-

  Asghar, Atif H ^a  

^a UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

Antibiotic resistance; Makkah hospitals; Metallo lactamases; Nosocomial infections; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CIPROFLOXACIN; COTRIFAMOLE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLA GENE; CHILD; ENZYME SYNTHESIS; FEMALE; GENITAL TRACT INFECTION; HUMAN; INFANT; INFECTION RATE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; SAUDI ARABIA; SCHOOL CHILD; URINARY TRACT INFECTION; WARD; WOUND INFECTION;

EID: 84865636151     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Vilma Almeida Paixão, Tânia Fraga Barros, Clélia Maria C Mota, Tamy Fagundes Moreira, Maria Angélica Santana, Joice Neves Reis. Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cyctic fibrosis. Braz J Infect Dis. 2010;14(4):406-409.
2. Pollack M. Pseudomonas aeruginosa. In: Mandell G, Bennett J, Dolin R (eds.). Principles and practice of infectious diseases. Philadelphia, Pa: Churchill Livingstone, 2000: 2310-2335.
3. Kerr KG, Snelling AM. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect. 2009;73(4):338-344.
4. Todar K. Todar'sonline textbook of bacteriology,university of wisconson: Madison; 2011.
5. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? ClinMicrobiol Rev. 2005;18(2):306-325.
6. Queenan A, Bush K. Carbapenemases: the versatile betalactamases. ClinMicrobiol. 2007;20(3):440-458.
7. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect. 2002;8(6):321-331.
8. Karlowsky JA, Draghi DC, Jones ME, Clyde Thornsberry, Ian R, Daniel F. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacterbaumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother. 2003;47(5):1681-1688.
9. Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC. Beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiellapneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother.1998;42(6):1350-1354.
10. Lee S, Kim J, Lee SK, Jin W, Kang SG, Lee KG. Discriminatory detection of extended-spectrum beta-lactamases by restriction fragment length dimorphism-polymerase chain reaction. LettApplMicrobiol. 2000;31(4):307-312.
11. Asghar AH, Faidah HS. Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from 2 hospitals in Makkah, Saudi Arabia. Saudi Med J. 2009;30(8):1017-1023.
12. Balkhy H, Cunningham G, Chew F, Francis C, Al-Nakhli D J, Al-Muneef MA, et.al. Hospital- and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis. 2006;10(4):333.
13. Khan J, Iqpal Z, Rahman S, Farzana K, Khan A. Prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics. Pak J Pharm Sci. 2008;21(3):311-315.
14. Jarvis W. Preventing the emergence of multidrug resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemiol.1996;17(8):490-495.
15. Qari F, Akbar D. Diabetic foot: presentation and treatment. Saudi Med J. 2000;21(5):443-446.
16. Al-Tawfiq J. Occurrence and antimicrobial resistance pattern of inpatient and outpatient isolates of Pseudomonas aeruginosa in a Saudi Arabian hospital: 1998-2003. Int J Infect Dis.2007;11(2):109-114.
17. Yoo J, Ohn E, Chung G. Prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics. DiagnMicrobiol Infect Dis 2010;41:307-310.
18. Bennett J. Nosocomial infections due to Pseudomonas. J Infect Dis. 1974; 130.
19. Memish Z. Communicable and non-communicable health hazards and current guidance for pilgrims. Euro Surveill. 2010;15(39):1-4.
20. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992-June 2004. Am J Infect Control. 2004;32:470-485.
21. Bonfiglio G, Carciotto V, Russo GS, Stefani, GC Schto, E Debbia et.al. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. J AntimicrobChemother. 2010;41(2):307-310.
22. Hancock R. Resistance mechanisms in Pseudomonas aeruginosa and other non-fermentative gram-negative bacteria. Clin Infect Dis. 1998;27:93-99.
23. Al-Agamy M, Shibl A, Zaki S, Tawfik A. Antimicrobial resistance pattern and prevalence of metallo-betalactamases in Pseudomonas aeruginosa from Saudi Arabia. African J Microbiology Research. 2011;5(30):5528-33.
24. Dong F, Xu X, Song W, Lu P, YU SJ, Yang YH et.al. Characterization of multidrug-resistant and metallobetalactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China. Chin Med J. 2008;121(17):1611-1616.
25. Bahar M, Jamali S, Samadikuchaksaraei A. Imipenemresistant Pseudomonas aeruginosa strains carry metallobeta-lactamase gene blaVIM in a level I Iranian burn hospital. Burns. 2010;36(6):826-30.
26. Lee MF, Peng CF, Hsu HJ, Chen YH. Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents.2008;32(6):475-80.
27. Altoparlak U, Aktas F, Celebi D, Ozkurt Z, Akcay MN. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacterbaumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates. Burns. 2005;31(6):707-10.